Effect of Kinesiotaping on Tremor in People With Parkinson's Disease

Summary

The goal of this clinical trial is to learn whether adding kinesiotaping to a strengthening and stretching home-exercise program can reduce hand tremor and improve hand function in people with Parkinson's disease. The study will also examine how true kinesiotaping compares with sham (placebo) taping and with exercise alone in improving tremor frequency, grip strength, fine motor skills, motor symptoms, daily living activities, and quality of life.

Adults aged 18-80 with Parkinson's disease and hand tremor will be randomly assigned to one of three groups:

Kinesiotaping + Exercise Group: Participants will receive therapeutic kinesiotaping applied to the forearm extensor muscles and wrist for 4 weeks (twice weekly), in addition to a home program of strengthening and stretching exercises.

Sham Taping + Exercise Group: Participants will receive a placebo taping without tension that does not target specific muscles, along with the same exercise program.

Exercise-Only Group: Participants will complete the same home-exercise program without any taping.

Researchers will compare the three groups to see whether kinesiotaping provides additional benefits beyond exercise and whether it performs better than sham taping. Tremor frequency will be measured using an Apple Watch device, and hand strength, dexterity, motor symptoms, and quality of life will be assessed using validated clinical scales.

Conditions

• PARKINSON DISEASE (Disorder)
• Tremor
• Tremor Associated With Tremor Dominant Parkinson's Disease

Interventions

OTHER

Therapeutic Kinesiotaping

Kinesiotaping applied to forearm extensor muscles with therapeutic tension and direction, twice weekly for 4 weeks

OTHER

Sham Taping

Placebo taping applied without therapeutic tension and without muscle alignment, twice weekly for 4 weeks

BEHAVIORAL

Home Exercise Program

Daily strengthening and stretching exercises targeting forearm muscles, performed for 4 weeks.

Sponsors & Collaborators

• Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

  lead OTHER

Principal Investigators

• Mehmet Akif Guler · University of Health Sciences, Sultan 2. Abdulhamid Han Training and Research Hospital

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

80 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2025-03-01

Primary Completion

2025-11-01

Completion

2026-01-01

Countries

• Turkey (Türkiye)

Study Locations